USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
APC BIOTECHNOLOGY SERVICES, INC.
Address:
APC BIOTECHNOLOGY SERVICES, INC.
9610 Medical Center Drive
Rockville, MD 20850
Phone:
N/A
URL:
N/A
EIN:
342052911
DUNS:
608276296
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $169,501.00 1
SBIR Phase II $750,000.00 1
STTR Phase I $150,000.00 1

Award List:

Development of Novel Bioprocess Platform for Rapid, Economical Production of Pept

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$169,501.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): A novel bioprocess platform, involving synthesis of peptide and protein biopharmaceutical products as fusions with a synthetic anchor protein in bacteria, and subsequent proteolytic cleavage, will be developed. The un ique features of the system allow for the… More

STTR Phase I: Novel Production Platform for Synthesis of Toxic Enzymes

Award Year / Program / Phase:
2008 / STTR / Phase I
Award Amount:
$150,000.00
Agency:
NSF
Principal Investigator:
Research Institution:
Princeton University
RI Contact:
David Wood
Abstract:
This Small Business Technology Transfer Phase I research develops a novel bioprocess platform for the synthesis of toxic enzymes as inactive pro-enzymes in bacteria that can subsequently be activated via simple pH and/or temperature shifts. Recombinant enzymes for industrial synthetic applications… More

Development of Novel Bioprocess Platform for Rapid, Economical Production of Pept

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$750,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): A novel bioprocess platform, involving synthesis of peptide and protein biopharmaceutical products as fusions with a synthetic anchor protein in bacteria, and subsequent proteolytic cleavage, has been developed. The u nique features of the system allow for the… More